CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
12:33, 27 февраля 2026Экономика
。heLLoword翻译官方下载是该领域的重要参考
9VitestStrong DefaultTesting
FT Edit: Access on iOS and web